![]() |
Quote:
|
good point guys... next medical purchase. One TQ for trauma-pouch, and one to have in the car. You never know, indeed. It may save someone's life.
|
Quote:
|
Quote:
|
Quote:
Problem with granules is if you have a decent sized arterial or venous injury , they could and can get intra vascular and cause BIG problems which is why the US military and law enforcement no longer promote the use of granular products. Send me an address, I'll hook you up. |
Quote:
I have some granular clotting agent and some infused bandage clotting agent too... direct pressure is best to start, if you have the time - The SWAT-T seems to be the most scalable item I have for that... start light, then go tight, if that don't work - stop the squirt. An 18D mantra from the old days. |
Quote:
If Quick Clot is all you can get, that will work in a pinch, but not preferred. |
The older Quick Clot cooked the tissues and was a real bear to remove.
The granules get hot with any kind of water application, so rinsing them out during treatment was not possible without creating more damage. The newer formulas are much better, as are the gauze products. Most of the expedient TQs are hard to place and tighten with one hand. The better designs help with that problem. TR |
The older quik clot is the exothermic (granules). Their combat gauze does not cause any temperature change or tissue interaction and is the preferred clot promoting product in my book and I have used all products on the market presently. The gauze is impregnated with kaolin, it's benign and it works when packed correctly. If you go to the z-Medica website they have instructional videos and on line training for its proper use.
As far as tourniquets, the SWAT-T, SOF-T are the two I prefer with the CAT last for ease of use and appropriate apication under stress. |
Quote:
|
Quote:
ss |
I would take the word of a trauma surgeon that I knew for it every time, but that is just me.
TR |
I agree with TR, I'll go with the Trauma Surgeon I know and trust to give me the best guidance he can.
|
Quote:
Comparison of novel hemostatic dressings with QuikClot combat gauze in a standardized swine model of uncontrolled hemorrhage Jason M. Rall, PhD, Jennifer M. Cox, BS, Adam G. Songer, MD, Ramon F. Cestero, MD, and James D. Ross, PhD, San Antonio, Texas BACKGROUND: Uncontrolled hemorrhage is the leading cause of preventable death on the battlefield. The development, testing, and application of novel hemostatic dressings may lead to a reduction of prehospitalmortality through enhanced point-of-injury hemostatic control. This study aimed to determine the efficacy of currently available hemostatic dressings as compared with the current Committee for Tactical Combat Casualty Care Guidelines standard of treatment for hemorrhage control (QuikClot Combat Gauze [QCG]). METHODS: The femoral artery of anesthetized Yorkshire pigs was isolated and punctured. Free bleeding was allowed to proceed for 45 seconds before packing of QCG, QuikClot Combat Gauze XL (QCX), Celox Trauma Gauze (CTG), Celox Gauze (CEL), or HemCon ChitoGauze (HCG), into the wound. After 3 minutes of applied, direct pressure, fluid resuscitation was administered to elevate and maintain a mean arterial pressure of 60mmHg or greater during the 150-minute observation time.Animal survival, hemostasis, and blood lossweremeasured as primary end points. Hemodynamic and physiologic parameters, along with markers of coagulation, were recorded and analyzed. RESULTS: Sixty percent ofQCG-treated animals (controls) survived through the 150-minute observation period.QCX, CEL, andHCGwere observed to have higher rates of survival in comparison to QCG (70%, 90%, and 70% respectively), although these results were not found to be of statistical significance in pairwise comparison to QCG. Immediate hemostasis was achieved in 30% of QCG applications, 80% of QCX, 70% of CEL, 60% of HCG, and 30% of CTG-treated animals. Posttreatment blood loss varied from an average of 64 mL/kg with CTG to 29 mL/kg with CEL, but no significant difference among groups was observed. CONCLUSION: These results suggest that the novel hemostatic devices perform at least as well as the current Committee on Tactical Combat Casualty Care standard for point-of-injury hemorrhage control. Despite their different compositions and sizes, the lack of clear superiority of any agent suggests that contemporary hemostatic dressing technology has potentially reached a plateau for efficacy. (J Trauma Acute Care Surg. 2013;75: S150YS156. Copyright * 2013 by Lippincott Williams & Wilkins) KEY WORDS: Hemostatics; hemostatic: dressings; hemostatic: gauze; hemorrhage: swine. |
Quote:
|
| All times are GMT -6. The time now is 09:29. |
Copyright 2004-2022 by Professional Soldiers ®